Concern for azotemia with angiotensin-converting enzyme inhibitors: public health implications and clinical relevance.
Bart
B A
BA
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D004656:Enalapril / Q000009:adverse effects* / Q000627:therapeutic use; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000187:drug effects* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000139:chemically induced*; D014511:Uremia / Q000139:chemically induced*; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril